Health technology company Kalderos has made waves in the 340B world in recent years after emerging as a key player [...] …
Category: Other Industry
Maxor, a leading integrated pharmacy services and 340B solutions provider first established nearly 100 years ago in a small Texas [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Two influential players in the 340B world have recently taken on key positions at retail pharmacy giant Walgreens, one of [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Several major 340B service companies announced mergers and acquisitions this week that officials said will expand their offerings and resources [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Hospitals in the 340B program should respond to increasing drugmaker contract pharmacy restrictions by opening their own pharmacies or selectively [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
CVS Health recently cited drug manufacturers’ contract pharmacy restrictions as one of the causes for a 19% year-over-year income decline [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Health system consulting firm Visante on Monday received a first-ever investment from a private equity firm and undertook planned changes [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Months after it was expected, bipartisan legislation to prevent drugmaker restrictions on the use of contract pharmacies by 340B providers [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
340B Report, the indispensable source for news and intelligence on the 340B drug pricing program, has added two team members with deep health care journalism experience. Rich Daly, a veteran healthcare business and policy journalist, is 340B Report’s new editor
…
A new “playbook” for employers on getting the upper hand with pharmacy benefit managers says PBM handling of 340B drugs is a top 10 concern for business-sponsored health plans.
Released yesterday by the Washington, D.C., based National Alliance of Healthcare
…